The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction

Abstract The study aimed to assess the clinical significance of selected single nucleotide polymorphisms (SNPs) in patients with diastolic heart failure (HF): inflammation [-174 G/C Interleukin -6 (IL-6) rs1800795, tumor necrosis factor (TNF)-608 G/A rs1800629], fibrosis [Arg25Pro transforming growt...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Agata Bielecka-Dabrowa, Agata Sakowicz, Tadeusz Pietrucha, Małgorzata Misztal, Piotr Chruściel, Jacek Rysz, Maciej Banach
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b7f17e42c1f24049821f3a6eabad2502
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b7f17e42c1f24049821f3a6eabad2502
record_format dspace
spelling oai:doaj.org-article:b7f17e42c1f24049821f3a6eabad25022021-12-02T16:06:00ZThe profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction10.1038/s41598-017-09564-92045-2322https://doaj.org/article/b7f17e42c1f24049821f3a6eabad25022017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-09564-9https://doaj.org/toc/2045-2322Abstract The study aimed to assess the clinical significance of selected single nucleotide polymorphisms (SNPs) in patients with diastolic heart failure (HF): inflammation [-174 G/C Interleukin -6 (IL-6) rs1800795, tumor necrosis factor (TNF)-608 G/A rs1800629], fibrosis [Arg25Pro transforming growth factor β (TGF β) rs1800471], endothelial function [-786 T/C nitric oxide synthase (NOS) rs2070744], glucose and lipid metabolism [Pro12Ala peroxisome proliferator activated receptor (PPAR)γ rs1801282], and vitamin D metabolism [cytochrome P450 27B1 (CYP27B1) C-1260A].110 patients with HF with preserved and mid-range ejection fraction (HFpEF and HFmrEF) were recruited. GG homozygotes in 174 G/C of IL6 polymorphism are characterized by higher values of estimated glomerular filtration rate based on the study Modification of Diet in Renal Disease (eGFR MDRD) and C allele in the NOS polymorphism and AA profile in C-1260A of CYP27B1 polymorphism correlated with a lower eGFR (MDRD). In multivariate analysis the CG genotype for 174 G/C of IL-6 and allele A in C-1260A of CYP27B1 are the only SNPs independently associated with worse course of HFpEF and HFmrEF. These data confirm the importance of the selected SNPs in aggravation and complications of hypertension.Agata Bielecka-DabrowaAgata SakowiczTadeusz PietruchaMałgorzata MisztalPiotr ChruścielJacek RyszMaciej BanachNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Agata Bielecka-Dabrowa
Agata Sakowicz
Tadeusz Pietrucha
Małgorzata Misztal
Piotr Chruściel
Jacek Rysz
Maciej Banach
The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction
description Abstract The study aimed to assess the clinical significance of selected single nucleotide polymorphisms (SNPs) in patients with diastolic heart failure (HF): inflammation [-174 G/C Interleukin -6 (IL-6) rs1800795, tumor necrosis factor (TNF)-608 G/A rs1800629], fibrosis [Arg25Pro transforming growth factor β (TGF β) rs1800471], endothelial function [-786 T/C nitric oxide synthase (NOS) rs2070744], glucose and lipid metabolism [Pro12Ala peroxisome proliferator activated receptor (PPAR)γ rs1801282], and vitamin D metabolism [cytochrome P450 27B1 (CYP27B1) C-1260A].110 patients with HF with preserved and mid-range ejection fraction (HFpEF and HFmrEF) were recruited. GG homozygotes in 174 G/C of IL6 polymorphism are characterized by higher values of estimated glomerular filtration rate based on the study Modification of Diet in Renal Disease (eGFR MDRD) and C allele in the NOS polymorphism and AA profile in C-1260A of CYP27B1 polymorphism correlated with a lower eGFR (MDRD). In multivariate analysis the CG genotype for 174 G/C of IL-6 and allele A in C-1260A of CYP27B1 are the only SNPs independently associated with worse course of HFpEF and HFmrEF. These data confirm the importance of the selected SNPs in aggravation and complications of hypertension.
format article
author Agata Bielecka-Dabrowa
Agata Sakowicz
Tadeusz Pietrucha
Małgorzata Misztal
Piotr Chruściel
Jacek Rysz
Maciej Banach
author_facet Agata Bielecka-Dabrowa
Agata Sakowicz
Tadeusz Pietrucha
Małgorzata Misztal
Piotr Chruściel
Jacek Rysz
Maciej Banach
author_sort Agata Bielecka-Dabrowa
title The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction
title_short The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction
title_full The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction
title_fullStr The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction
title_full_unstemmed The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction
title_sort profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/b7f17e42c1f24049821f3a6eabad2502
work_keys_str_mv AT agatabieleckadabrowa theprofileofselectedsinglenucleotidepolymorphismsinpatientswithhypertensionandheartfailurewithpreservedandmidrangeejectionfraction
AT agatasakowicz theprofileofselectedsinglenucleotidepolymorphismsinpatientswithhypertensionandheartfailurewithpreservedandmidrangeejectionfraction
AT tadeuszpietrucha theprofileofselectedsinglenucleotidepolymorphismsinpatientswithhypertensionandheartfailurewithpreservedandmidrangeejectionfraction
AT małgorzatamisztal theprofileofselectedsinglenucleotidepolymorphismsinpatientswithhypertensionandheartfailurewithpreservedandmidrangeejectionfraction
AT piotrchrusciel theprofileofselectedsinglenucleotidepolymorphismsinpatientswithhypertensionandheartfailurewithpreservedandmidrangeejectionfraction
AT jacekrysz theprofileofselectedsinglenucleotidepolymorphismsinpatientswithhypertensionandheartfailurewithpreservedandmidrangeejectionfraction
AT maciejbanach theprofileofselectedsinglenucleotidepolymorphismsinpatientswithhypertensionandheartfailurewithpreservedandmidrangeejectionfraction
AT agatabieleckadabrowa profileofselectedsinglenucleotidepolymorphismsinpatientswithhypertensionandheartfailurewithpreservedandmidrangeejectionfraction
AT agatasakowicz profileofselectedsinglenucleotidepolymorphismsinpatientswithhypertensionandheartfailurewithpreservedandmidrangeejectionfraction
AT tadeuszpietrucha profileofselectedsinglenucleotidepolymorphismsinpatientswithhypertensionandheartfailurewithpreservedandmidrangeejectionfraction
AT małgorzatamisztal profileofselectedsinglenucleotidepolymorphismsinpatientswithhypertensionandheartfailurewithpreservedandmidrangeejectionfraction
AT piotrchrusciel profileofselectedsinglenucleotidepolymorphismsinpatientswithhypertensionandheartfailurewithpreservedandmidrangeejectionfraction
AT jacekrysz profileofselectedsinglenucleotidepolymorphismsinpatientswithhypertensionandheartfailurewithpreservedandmidrangeejectionfraction
AT maciejbanach profileofselectedsinglenucleotidepolymorphismsinpatientswithhypertensionandheartfailurewithpreservedandmidrangeejectionfraction
_version_ 1718385171832504320